10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -206,147 | -113,161 | -50,747 | -166,000 | -148,785 |
| Depreciation Amortization | 31,913 | 20,493 | 8,616 | 33,006 | 24,534 |
| Accounts receivable | 361 | 16,526 | 26,279 | -18,948 | 1,673 |
| Accounts payable and accrued liabilities | -2,811 | 1,314 | -781 | 5,858 | 6,082 |
| Other Working Capital | 277 | -15,893 | -5,960 | -40,342 | -20,072 |
| Other Operating Activity | 135,452 | 75,070 | 18,468 | 152,820 | 89,239 |
| Operating Cash Flow | $-40,955 | $-15,651 | $-4,125 | $-33,606 | $-47,329 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 166,468 | 146,132 | 125,238 | -215,226 | -224,288 |
| PPE Investments | -45,151 | -29,915 | -4,559 | -131,661 | -91,927 |
| Net Acquisitions | N/A | N/A | N/A | -4,000 | -1,500 |
| Purchase Sale Intangibles | -923 | -723 | -723 | N/A | N/A |
| Other Investing Activity | -923 | -723 | -723 | 0 | 0 |
| Investing Cash Flow | $120,394 | $115,494 | $119,956 | $-350,887 | $-317,715 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,814 | -5,814 | -5,814 | -5,409 | -5,409 |
| Common Stock Issued | 13,870 | 9,496 | 2,400 | 21,226 | 16,225 |
| Financing Cash Flow | $8,056 | $3,682 | $-3,414 | $15,817 | $10,816 |
| Exchange Rate Effect | -110 | -25 | 24 | -44 | -295 |
| Beginning Cash Position | 227,353 | 227,353 | 227,353 | 596,073 | 596,073 |
| End Cash Position | 314,738 | 330,853 | 339,794 | 227,353 | 241,550 |
| Net Cash Flow | $87,385 | $103,500 | $112,441 | $-368,720 | $-354,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,955 | -15,651 | -4,125 | -33,606 | -47,329 |
| Capital Expenditure | -45,151 | -29,915 | -4,559 | -131,661 | -91,927 |
| Free Cash Flow | -86,106 | -45,566 | -8,684 | -165,267 | -139,256 |